Seeking Alpha

More on Quest Diagnostics (DGX -4.1%) Q2: net profit +9% to $178M, helped by lower expenses as...

More on Quest Diagnostics (DGX -4.1%) Q2: net profit +9% to $178M, helped by lower expenses as revenue barely rises. Cuts FY sales growth outlook to 1%-2% from 2%-2.5% prior but maintains EPS outlook at $4.45-$4.60 vs. consensus of $4.60. Also lowers cap-spending plans to $200M from $200M-$225M prior.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|